1-3 of 3
Nikolai Podoltsev
Close
Sort by
Journal Articles

Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia

Kishan K. Patel, Amer M. Zeidan, Rory M. Shallis, Thomas Prebet, Nikolai Podoltsev, Scott F. Huntington
Journal: Blood Advances
Blood Adv (2021) 5 (4): 994–1002.
https://doi.org/10.1182/bloodadvances.2020003902
Published: 2021
Includes: Supplemental data
Journal Articles

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab

Clinical Trials & Observations
Talha Badar, Aniko Szabo, Anjali Advani, Martha Wadleigh, Shukaib Arslan, Muhammad Ali Khan, Ibrahim Aldoss, Caitlin Siebenaller, Elizabeth Schultz, Mehrdad Hefazi, Rory M. Shallis, Ilana Yurkiewicz, Nikolai Podoltsev, Anand A. Patel, Emily Curran, Suresh Balasubramanian, Jay Yang, Ryan J. Mattison, Madelyn Burkart, Shira Dinner, Michaela Liedtke, Mark R. Litzow, Ehab Atallah
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2308–2316.
https://doi.org/10.1182/bloodadvances.2019001381
Published: 2020
Includes: Supplemental data
Journal Articles

Chromosome 1 abnormalities and survival of patients with multiple myeloma in the era of novel agents

Clinical Trials & Observations
Smith Giri, Scott F. Huntington, Rong Wang, Amer M. Zeidan, Nikolai Podoltsev, Steven D. Gore, Xiaomei Ma, Cary P. Gross, Amy J. Davidoff, Natalia Neparidze
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2245–2253.
https://doi.org/10.1182/bloodadvances.2019001425
Published: 2020